New study aims to predict risk of cancer

October 16, 2012

New research at the University of Southampton aims to develop a way of predicting who is more at risk of getting cancer.

Led by Paul Little, Professor of Primary Care Research, the CANcer DIagnosis Decision rules (CANDID) study, funded by the National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR), will collect and analyse clinical information and blood samples from 20,000 patients who have had lung or colon cancer. The aim is to determine which signs and symptoms are most predictive of those who go on to be diagnosed with the disease.

Genetic testing will be carried out after the recruitment phase of the study to establish how much extra information genetics provides over and above the clinical information.

The £2 million five-year study is the largest award made by the NIHR SPCR and aims to improve the referral process patients go through before being diagnosed. Currently GPs must refer urgent cases within two weeks and for other cases, up to 62 days for referral; however it has been reported that some patients have to wait much longer and some have visited their GP more than once before being referred.

Professor Little comments: "We need to improve both the early referral rates for cancer but, at the same time, we do not want to overload the system with lots of people who are at a low risk of having cancer and may have negative side-effects of being over-investigated. Waiting for results and dealing with the possibility of having cancer can be a distressing and daunting time for patients and their families, our research aims to aid the patient pathway and help medical professionals, so every patient is dealt with in the most appropriate way and in a timely fashion."

The study will use patient samples from the eight centres within the NIHR National School for Primary Research: Southampton, Oxford, Bristol, Birmingham, Nottingham, University College London, Manchester and Keele.

The NIHR SPCR Director, Professor Richard Hobbs adds: 'The NIHR School for Primary Care Research is pleased to be supporting this ambitious new study, the funding for which was made possible after we had redesigned the way that the School funds its research to enable larger, collaborative, longer term research to compete with short term single centre studies.

"The UK presently spends only around 5 per cent of its overall health research budgets on prevention and for many diseases, and cancer in particular, the earlier it is recognised and diagnosed, the better the prognosis or outcomes. This is why CANDID is important for patients and the NHS. Pleasingly, this major prospective research also builds on earlier research into symptoms that may predict cancer based on retrospective data, some of which was also supported by the NIHR SPCR."

University of Southampton

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to